ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 24 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,300 | +0.5% | 288,194 | -9.7% | 0.01% | +20.0% |
| Q2 2023 | $3,282 | +28.7% | 319,294 | -3.3% | 0.01% | +66.7% |
| Q1 2023 | $2,550 | +4.2% | 330,294 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $2,447 | -99.9% | 332,894 | -7.2% | 0.00% | -25.0% |
| Q3 2022 | $2,583,000 | -23.6% | 358,694 | -9.7% | 0.00% | 0.0% |
| Q2 2022 | $3,382,000 | -2.3% | 397,394 | +2.9% | 0.00% | 0.0% |
| Q1 2022 | $3,463,000 | -35.3% | 386,094 | -0.1% | 0.00% | -42.9% |
| Q4 2021 | $5,350,000 | +26.7% | 386,294 | -2.4% | 0.01% | +40.0% |
| Q3 2021 | $4,221,000 | +17.5% | 395,594 | -0.9% | 0.01% | +25.0% |
| Q2 2021 | $3,591,000 | -14.6% | 398,994 | +0.5% | 0.00% | -20.0% |
| Q1 2021 | $4,207,000 | -27.2% | 396,894 | -13.5% | 0.01% | -16.7% |
| Q4 2020 | $5,781,000 | +69.2% | 458,794 | +18.0% | 0.01% | +100.0% |
| Q3 2020 | $3,417,000 | +56.7% | 388,683 | +73.0% | 0.00% | +50.0% |
| Q2 2020 | $2,181,000 | +469.5% | 224,655 | +68.7% | 0.00% | – |
| Q1 2020 | $383,000 | -22.0% | 133,155 | +4.2% | 0.00% | – |
| Q4 2019 | $491,000 | +10.3% | 127,810 | +13.7% | 0.00% | – |
| Q3 2019 | $445,000 | -0.4% | 112,361 | +5.7% | 0.00% | – |
| Q2 2019 | $447,000 | -32.1% | 106,261 | +10.8% | 0.00% | -100.0% |
| Q1 2019 | $658,000 | +105.0% | 95,861 | +9.8% | 0.00% | – |
| Q4 2018 | $321,000 | -55.6% | 87,292 | -23.6% | 0.00% | -100.0% |
| Q3 2018 | $723,000 | -58.4% | 114,274 | -48.9% | 0.00% | 0.0% |
| Q2 2018 | $1,737,000 | +114.4% | 223,724 | +120.9% | 0.00% | 0.0% |
| Q1 2018 | $810,000 | +7.1% | 101,300 | +50.1% | 0.00% | 0.0% |
| Q4 2017 | $756,000 | +25.4% | 67,500 | +29.9% | 0.00% | 0.0% |
| Q3 2017 | $603,000 | – | 51,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $23,143,000 | 2.13% |
| Omega Fund Management, LLC | 1,284,900 | $11,564,000 | 1.31% |
| Avidity Partners Management LP | 1,495,000 | $13,455,000 | 0.36% |
| Samsara BioCapital, LLC | 275,169 | $2,477,000 | 0.31% |
| Orbimed Advisors | 3,070,955 | $27,639,000 | 0.28% |
| Ikarian Capital, LLC | 300,454 | $2,704,000 | 0.22% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,240,000 | 0.22% |
| DAFNA Capital Management LLC | 113,302 | $1,020,000 | 0.21% |
| EcoR1 Capital, LLC | 522,635 | $4,704,000 | 0.18% |
| Artal Group S.A. | 593,030 | $5,337,000 | 0.11% |